Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Charles A. O’Neill
Neutral Endopeptidase-Resistant C-Type Natriuretic Peptide Variant Represents a New Therapeutic Approach for Treatment of Fibroblast Growth Factor Receptor 3-Related Dwarfism
Journal of Pharmacology and Experimental Therapeutics
Molecular Medicine
Pharmacology
Related publications
Role of Fibroblast Growth Factor Receptor 2 in Pancreatic Cancer: Potential Target for New Therapeutic Approach?
Pancreatic Disorders and Therapy
Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Endothelial Production of C-Type Natriuretic Peptide and Its Marked Augmentation by Transforming Growth Factor-Beta. Possible Existence of "Vascular Natriuretic Peptide System".
Journal of Clinical Investigation
Medicine
Effect of Thanatophoric Dysplasia Type I Mutations on Fibroblast Growth Factor Receptor 3 Dimerization
Biophysical Journal
Biophysics
Competitive Binding of Musclin to Natriuretic Peptide Receptor 3 With Atrial Natriuretic Peptide
Journal of Endocrinology
Endocrinology
Metabolism
Diabetes
Fibroblast Growth Factor Receptor (FGFR)
Science-Business eXchange
Therapeutic Potential of Epidermal Growth Factor Receptor-Related Protein
Molecular Cancer Therapeutics
Cancer Research
Oncology
Fibroblast Growth Factor Receptor 3-IIIc Mediates Colorectal Cancer Growth and Migration
British Journal of Cancer
Cancer Research
Oncology
C-Type Natriuretic Peptide Restores Impaired Skeletal Growth in a Murine Model of Glucocorticoid-Induced Growth Retardation
Bone
Endocrinology
Physiology
Histology
Metabolism
Diabetes